CytomX Therapeutics(CH:6C1)
CH:6C1
CytomX Therapeutics earnings date
CytomX Therapeutics (6C1) Q2 2022 Earnings Report
0 Followers
CH:6C1 Q2 2022 EPS Results
- Actual EPS
- -CHF 0.31
- Consensus EPS
- -CHF 0.31
- Beat/Miss
- Beat by +CHF 0.00
- One Year Ago EPS
- -CHF 0.25
CH:6C1 Q2 2022 Revenue Results
- Actual Revenue
- CHF 15.12M
- Expected Revenue
- CHF 15.08M
- Beat/Miss
- Beat by +CHF 41.61K
- YoY Revenue Growth
- +11.52%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/04/2022
- Time
- After Close
- Conference Call
- Thursday, August 4, 2022
CH:6C1 Upcoming Earnings
CytomX Therapeutics's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:6C1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | -0.07- | -0.14 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.06-0.07 | -0.07 | 0.00% (+0.00) | |
| Aug 06, 2026 | 2026 (Q2) | -0.06-0.07 | 0 | ― | |
| May 07, 2026 | 2026 (Q1) | -0.10-0.08 | 0.22 | -137.04% (-0.31) | |
| Mar 16, 2026 | 2025 (Q4) | -0.08-0.14 | 0.18 | -178.64% (-0.33) | |
| Nov 06, 2025 | 2025 (Q3) | -0.04-0.07 | 0.06 | -228.57% (-0.13) | |
| Aug 07, 2025 | 2025 (Q2) | -0.050.00 | -0.07 | 100.00% (+0.07) | |
| May 12, 2025 | 2025 (Q1) | 0.100.22 | 0.14 | 58.82% (+0.08) | |
| Mar 06, 2025 | 2024 (Q4) | -0.160.18 | 0.02 | 1000.00% (+0.17) | |
| Nov 07, 2024 | 2024 (Q3) | -0.140.06 | 0.03 | 75.00% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
